was read the article
array:23 [ "pii" => "S0300289615324844" "issn" => "03002896" "doi" => "10.1016/S0300-2896(15)32484-4" "estado" => "S300" "fechaPublicacion" => "1980-07-01" "aid" => "72553" "copyright" => "Sociedad Española de Neumología y Cirugía Torácica" "copyrightAnyo" => "1980" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "abs" "cita" => "Arch Bronconeumol. 1980;16:135" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 910 "formatos" => array:3 [ "EPUB" => 43 "HTML" => 452 "PDF" => 415 ] ] "itemSiguiente" => array:18 [ "pii" => "S0300289615324856" "issn" => "03002896" "doi" => "10.1016/S0300-2896(15)32485-6" "estado" => "S300" "fechaPublicacion" => "1980-07-01" "aid" => "72554" "copyright" => "Sociedad Española de Neumología y Cirugía Torácica" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "abs" "cita" => "Arch Bronconeumol. 1980;16:135" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 906 "formatos" => array:3 [ "EPUB" => 42 "HTML" => 466 "PDF" => 398 ] ] "es" => array:8 [ "idiomaDefecto" => true "titulo" => "Tuberculosis in patients with end-stage renal disease" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "135" ] ] "contieneResumen" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289615324856?idApp=UINPBA00003Z" "url" => "/03002896/0000001600000003/v1_201509151256/S0300289615324856/v1_201509151256/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0300289615324832" "issn" => "03002896" "doi" => "10.1016/S0300-2896(15)32483-2" "estado" => "S300" "fechaPublicacion" => "1980-07-01" "aid" => "72552" "copyright" => "Sociedad Española de Neumología y Cirugía Torácica" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "abs" "cita" => "Arch Bronconeumol. 1980;16:135" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 913 "formatos" => array:3 [ "EPUB" => 44 "HTML" => 487 "PDF" => 382 ] ] "es" => array:8 [ "idiomaDefecto" => true "titulo" => "Cytotoxic drug-induced pulmonary disease: Update 1980" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "135" ] ] "contieneResumen" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289615324832?idApp=UINPBA00003Z" "url" => "/03002896/0000001600000003/v1_201509151256/S0300289615324832/v1_201509151256/es/main.assets" ] "es" => array:8 [ "idiomaDefecto" => true "titulo" => "Small Cel Carcinoma of the Lung. Experience with a six-drug Regimen" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "135" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "tieneResumen" => true "resumen" => array:1 [ "es" => array:1 [ "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Treinta y siete enfermos con carcinoma de células pequeñas pulmonar, sin tratamiento previo, fueron tratados con un programa alternativo de dos regímenes de 3 drogas compuesto por agentes activos individualmente y con diferentes mecanismos de acción farmacológica. Las dos fases terapéuticas consistían’en: 1) ciclofosfamida 100 mg/m<span class="elsevierStyleSup">2</span>, adriamicina 30 mg/m<span class="elsevierStyleSup">2</span> y vincristina 1,4 mg/m<span class="elsevierStyleSup">2</span> administrados todos ellos por vía endovenosa en los días 1 y 22 (régimen CAV). El segundo régimen (BMP) consistía en BCNU 100 mg/m<span class="elsevierStyleSup">2</span> i.v., los días 43 y 44; methrotrexate, 30 mg/m<span class="elsevierStyleSup">2</span> i.v., los días 50 y 64, y procarbazina 100 mg/m<span class="elsevierStyleSup">2</span> per los de los días 51 a 64. Los tratamientos se «reciclaban » con CAV el día 85.</p><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Se usó radioterapia para controlar la extensión del tumor localmente que no respondía a la quimioterapia y para paliar las molestias focales del cáncer progresivo.</p><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">De los 31 enfermos valorables para un análisis de la respuesta a la quimioterapia y a la radiación, el 70% demostraron una regresión tumoral completa o parcial (más del 50%) con duración de la respuesta de 7 meses de media con rango de 1 2 25 o meses. El tiempo de superviviencia media desde el inicio del tratamiento fue de 11,5 meses para enfermos con enfermedad limitada y 7,5 meses con extensión tumoral.</p><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">La toxicidad incluyó: náuses y vómitos en todos los pacientes, leucopenia (menos de 3.000 elementos) en 29% del grupo CAV y 27% del BMP con dos episodios de infección y una muerte, trombopenia (menos de 50.000 elementos en 3% de grupo CAV y 42% en el BMP).</p><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Este programa de seis drogas no se mostró superior a otros protocolos conocidos de 4 drogas.</p></span>" ] ] ] "idiomaDefecto" => "es" "url" => "/03002896/0000001600000003/v1_201509151256/S0300289615324844/v1_201509151256/es/main.assets" "Apartado" => array:4 [ "identificador" => "43822" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Referatas" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/03002896/0000001600000003/v1_201509151256/S0300289615324844/v1_201509151256/es/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289615324844?idApp=UINPBA00003Z" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 4 | 4 | 8 |
2024 October | 31 | 16 | 47 |
2024 September | 35 | 13 | 48 |
2024 August | 38 | 26 | 64 |
2024 July | 34 | 21 | 55 |
2024 June | 36 | 18 | 54 |
2024 May | 37 | 24 | 61 |
2024 April | 26 | 18 | 44 |
2024 March | 27 | 19 | 46 |
2024 February | 24 | 34 | 58 |
2024 January | 0 | 4 | 4 |
2023 December | 0 | 4 | 4 |
2023 November | 0 | 1 | 1 |
2023 October | 0 | 3 | 3 |
2023 September | 0 | 1 | 1 |
2023 August | 0 | 5 | 5 |
2023 July | 0 | 13 | 13 |
2023 April | 0 | 2 | 2 |
2023 March | 4 | 2 | 6 |
2023 February | 31 | 19 | 50 |
2023 January | 36 | 25 | 61 |
2022 December | 27 | 22 | 49 |
2022 November | 32 | 16 | 48 |
2022 October | 24 | 30 | 54 |
2022 September | 17 | 23 | 40 |
2022 August | 27 | 33 | 60 |
2022 July | 19 | 28 | 47 |
2022 June | 20 | 33 | 53 |
2022 May | 30 | 22 | 52 |
2022 April | 19 | 25 | 44 |
2022 March | 56 | 34 | 90 |
2022 February | 27 | 26 | 53 |
2022 January | 27 | 20 | 47 |
2021 December | 18 | 29 | 47 |
2021 November | 32 | 23 | 55 |
2021 October | 28 | 17 | 45 |
2021 September | 6 | 21 | 27 |
2021 August | 12 | 22 | 34 |
2021 July | 10 | 11 | 21 |
2021 June | 15 | 18 | 33 |
2021 May | 25 | 26 | 51 |
2021 April | 25 | 18 | 43 |
2021 March | 20 | 14 | 34 |
2021 February | 15 | 11 | 26 |
2021 January | 8 | 17 | 25 |
2020 December | 19 | 6 | 25 |
2020 November | 17 | 15 | 32 |
2020 October | 7 | 10 | 17 |
2020 September | 12 | 5 | 17 |
2020 August | 18 | 9 | 27 |
2020 July | 11 | 13 | 24 |
2020 June | 13 | 12 | 25 |
2020 May | 10 | 10 | 20 |
2020 April | 20 | 9 | 29 |
2020 March | 17 | 18 | 35 |
2020 February | 13 | 6 | 19 |
2020 January | 15 | 15 | 30 |
2019 December | 21 | 23 | 44 |
2019 November | 6 | 6 | 12 |
2019 October | 2 | 4 | 6 |
2019 September | 10 | 9 | 19 |
2019 August | 8 | 10 | 18 |
2019 July | 19 | 20 | 39 |
2019 June | 17 | 11 | 28 |
2019 May | 11 | 21 | 32 |
2019 April | 9 | 48 | 57 |
2019 March | 4 | 15 | 19 |
2019 February | 5 | 7 | 12 |
2019 January | 4 | 3 | 7 |
2018 December | 4 | 8 | 12 |
2018 November | 5 | 10 | 15 |
2018 October | 17 | 14 | 31 |
2018 September | 4 | 3 | 7 |
2018 May | 1 | 2 | 3 |
2018 April | 9 | 6 | 15 |
2018 March | 5 | 5 | 10 |
2018 February | 7 | 6 | 13 |
2018 January | 7 | 7 | 14 |
2017 December | 6 | 8 | 14 |
2017 November | 8 | 6 | 14 |
2017 October | 12 | 7 | 19 |
2017 September | 3 | 8 | 11 |
2017 August | 16 | 14 | 30 |
2017 July | 5 | 3 | 8 |
2017 June | 6 | 11 | 17 |
2017 May | 10 | 7 | 17 |
2017 April | 7 | 5 | 12 |
2017 March | 6 | 3 | 9 |
2017 February | 9 | 6 | 15 |
2017 January | 2 | 4 | 6 |
2016 December | 15 | 9 | 24 |
2016 November | 14 | 12 | 26 |
2016 October | 8 | 9 | 17 |
2016 September | 5 | 2 | 7 |
2016 August | 12 | 4 | 16 |
2016 July | 9 | 3 | 12 |
2016 June | 13 | 6 | 19 |
2016 May | 12 | 5 | 17 |
2016 April | 5 | 0 | 5 |
2016 March | 5 | 2 | 7 |
2016 February | 9 | 3 | 12 |
2016 January | 13 | 5 | 18 |
2015 December | 18 | 11 | 29 |
2015 November | 20 | 4 | 24 |
2015 October | 6 | 1 | 7 |
2015 September | 1 | 0 | 1 |